Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 1, 2024 | Baseimmune: Revolutionizing Vaccine Development with AI | London-based Baseimmune, a biotech company, has secured €10.4M in funding to develop mutation-proof vaccines using AI. Led by MSD Global Health Innovation Fund and IQ Capital, the funding will accelerate the development of three vaccine can... |
| Feb 27, 2024 | UK-based Baseimmune raises €10.4M to develop mutation-proof vaccines using AI; here’s how | Read this article in: London-based Baseimmune, a biotech company using deep learning AI to forecast pathogen mutations for vaccine development, has secured $11.3M (approximately €10.40M) in a Series A round of funding. The round was led by ... |
| Dec 2, 2022 | Hungarian-founded biotech startup Turbine raises €20M in series A round | Hungarian-founded biotech startup Turbine raises €20M in series A round 02 December, 2022, 09:54 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> The London-based company that deve... |
| Nov 22, 2022 | Cancer drugs forecasting startup Turbine secures €20 million series A | Turbine, a London-based startup that's working on cell simulators to predict how patients might benefit from new targeted cancer treatments, has raised €20 million in new funding. The round is billed as a series A and has attracted backing ... |
Reviews 0
FAQ about MSD Global Health Innovation Fund
What has the press written about MSD Global Health Innovation Fund?
Parsers VC has collected 5 articles mentioning MSD Global Health Innovation Fund, among them “Baseimmune: Revolutionizing Vaccine Development with AI” (Mar 1, 2024) and “UK-based Baseimmune raises €10.4M to develop mutation-proof vaccines using AI; here’s how” (Feb 27, 2024).
Is MSD Global Health Innovation Fund still active?
Yes, MSD Global Health Innovation Fund is active; its latest activity on Parsers VC dates from Sep 22, 2026.